Logo
SubscribeSign In
LeaderPortfolio
Billionaire Profile
H
Global Rank
#1070

Image: Job P. Wyatt and Sons Company Henry G. Gilbert Nursery and Seed Trade Catalog Collection | Public domain | via Wikimedia Commons

Henri Beaufour

CEO, Pharmaceuticals
FRANCE
Real-Time Net Worth
$3.862B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+1.91% (24h)
Age
60
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
FRANCE

Biography

Henri Beaufour, a prominent figure in the pharmaceutical and biotechnology sectors, passed away on November 28, 2025, at the age of 60. He was a French billionaire businessman, primarily known for his leadership within Ipsen, a global biopharmaceutical company. Through strategic investments and innovative drug development, Beaufour significantly impacted the healthcare industry. Educated at Georgetown University, he held a stake in Ipsen and was also an angel investor. Beaufour's family has a long history in the pharmaceutical industry. He was known for his philanthropic efforts.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Henri Beaufour was born on January 6, 1965, in Neuilly-sur-Seine, France. He was the son of Albert Beaufour, a successful businessman and former CEO of Ipsen Group, and the grandson of Dr. Henri Beaufour, who founded Beaufour Laboratories, the precursor to Ipsen, in 1929. He earned a Bachelor of Arts degree from Georgetown University.

Rise to Success

After graduating from Georgetown University, Henri Beaufour began his career in the pharmaceutical industry, joining Ipsen Group. He quickly rose through the ranks, holding various leadership positions. Following his father's death in 2000, Henri inherited a significant portion of the family's capital in Ipsen, becoming the majority shareholder alongside his sister Anne.

Key Business Strategies

Henri Beaufour, with his sister Anne, controlled about 52% of Ipsen, which generated revenues of more than $3.4 billion in 2022. His fortune was largely anchored in his stake in the pharmaceutical giant Ipsen, France's third-largest pharmaceutical company.

Philanthropy

Henri Beaufour was known for his philanthropic efforts and support of various charitable causes, particularly in cancer research and healthcare accessibility. He was involved in initiatives related to healthcare, education, and social welfare.

Career Milestones

2000

Inherited Ipsen Capital

Following his father's death, Henri inherited a significant portion of the family's capital in Ipsen.

2005

Board Member

Henri Beaufour was a board member of Ipsen S.A.

2025

Death

Henri Beaufour passed away on November 28, 2025.

Compare Henri Beaufour

Net Worth Face-off
Henri Beaufour vs Elon Musk
Compare Wealth →
Net Worth Face-off
Henri Beaufour vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Henri Beaufour vs Mark Zuckerberg
Compare Wealth →